Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2020-06-26 M&A Activity
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
M&A Activity Classification · 100% confidence The document is a press release dated June 26, 2020, announcing that Zur Rose Group is acquiring the mail-order and diabetes activities of Apotal Group. Key phrases like 'Takeover', 'acquisition', 'Financing through available cash and issuance of shares', and details about the transaction valuation and expected closing date clearly indicate a significant corporate transaction involving mergers or acquisitions. This aligns directly with the definition for M&A Activity (TAR). It is not an earnings release (ER), interim report (IR), or a formal regulatory filing like a 10-K.
2020-06-26 English
Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing
Legal Proceedings Report Classification · 99% confidence The document is a 'Press release' from Zur Rose Group AG, dated May 3, 2020, concerning legal charges filed against its CEO regarding past business practices (mail-order drugs and doctor compensation for e-prescriptions). It details the nature of the legal matter, the company's response, and historical context regarding court rulings. This content directly relates to significant legal proceedings and regulatory scrutiny involving the company and its management. This fits best under the 'Legal Proceedings Report' (LTR) category, as it is an update on a significant lawsuit/regulatory action. It is not an earnings release (ER), an annual report (10-K), or a management discussion (MDA), but specifically addresses legal matters.
2020-05-03 English
2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals
AGM Information Classification · 99% confidence The document explicitly discusses the '2020 Annual General Meeting of Zur Rose Group AG' and details the outcomes, such as shareholder approval of reports, ratification of board actions, and voting on compensation and capital structure changes. The key phrase is '2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals'. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the approval of the Annual Financial Statements for 2019, the primary focus and context of the release is the meeting itself, not the filing of the full 10-K or AR.
2020-04-23 English
Zur Rose Group starts 2020 with strong growth
Earnings Release Classification · 95% confidence The document is a press release titled 'Zur Rose Group starts 2020 with strong growth' issued on 16 April 2020. It provides a summary of quarterly financial performance (Q1 2020) including revenue figures and growth percentages. While it contains financial data, it is structured as a corporate news release (EQS Group-News) rather than a formal, comprehensive interim financial report. According to the filing definitions, an Earnings Release (ER) is the initial announcement of quarterly financial results containing key highlights, which matches this document perfectly. Q1 2020
2020-04-16 English
Geschäftsbericht 2019
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2019' (Annual Report 2019) for the Zur Rose Group. It contains a comprehensive table of contents, financial highlights, a letter to shareholders, detailed segment reporting, and consolidated financial statements. It is a full-length annual report, not an announcement or a summary. FY 2019
2020-04-11 German
Annual Report 2019
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2019 Zur Rose Group' and contains comprehensive sections including a letter to shareholders, key financials, segment analysis, corporate governance, compensation reports, and consolidated financial statements. It is a full-year report covering the 2019 fiscal period, which aligns perfectly with the definition of an Annual Report (10-K). FY 2019
2020-04-11 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.